Enzon Pharmaceuticals Files 10-K/A Amendment for Part III Info
Ticker: ENZN · Form: 10-K/A · Filed: Apr 28, 2025 · CIK: 727510
Sentiment: neutral
Topics: amendment, 10-K, governance
TL;DR
Enzon Pharma finally dropped the rest of its 2024 10-K, adding governance and exec pay details.
AI Summary
Enzon Pharmaceuticals, Inc. is filing an amendment (10-K/A) to its annual report for the year ended December 31, 2024. This amendment, filed on April 28, 2025, is to include Part III information (Items 10-14) which was due within 120 days of the fiscal year-end. The original annual report was filed on February 21, 2025.
Why It Matters
This filing provides crucial details about the company's governance, executive compensation, and security ownership, which are important for investors to assess management and potential conflicts of interest.
Risk Assessment
Risk Level: low — This is a routine amendment to a previously filed annual report, not indicating new material adverse events.
Key Players & Entities
- Enzon Pharmaceuticals, Inc. (company) — Filer of the amendment
- February 21, 2025 (date) — Original filing date of the annual report
- April 28, 2025 (date) — Filing date of this amendment
- December 31, 2024 (date) — Fiscal year end for the annual report
FAQ
What specific information is being added in this 10-K/A filing?
This amendment adds the information required by Items 10 through 14 of Part III of Form 10-K, which pertains to directors, executive officers and corporate governance, executive compensation, and security ownership of management and principal stockholders.
Why was this amendment filed separately from the original 10-K?
Part III Information is required to be filed no later than 120 days after the company's fiscal year-end, and this amendment ensures that requirement is met, as the original 10-K was filed earlier.
What is the original filing date of the 2024 annual report?
The original Annual Report on Form 10-K for the year ended December 31, 2024, was filed with the SEC on February 21, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the filing date of this amendment?
This Amendment No. 1 on Form 10-K/A was filed on April 28, 2025.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 28, 2025 regarding ENZON PHARMACEUTICALS, INC. (ENZN).